Add To Watchlist
Share URL
Pfizer Inc.
PFE: NYSELowest reading is at 43 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Dr. Albert Bourla D.V.M., Ph.D.
Market Cap
167.52 Billion USD
Sector
Healthcare
Website
https://www.pfizer.comLast Update
04/11/2026, 12:01:28
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Read More
Strongest readings
- ✔Cashflow and earnings growth is strong (growth score 62 out of 100)
- ✔Debt is low at 0.75 times equity
Weakest readings
- ✘Earnings have fallen this year (-59.83%)
- ✘A high share of income is paid out as dividend (225.83%)
- ✘Revenue is growing at 24.66% per year while free cashflow is falling
- ✘Price-to-earnings of 40.1 is above the market average of 19.6
- ✘Returns on capital have declined over five years (6.27% lower)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings (TTM) | 40.15x | 19.60x | |
| ✘ | Margin of safety (DCF) | -50.85% | 17.95% | |
| ✔ | Revenue growth (5y average) | 24.66% | 10.97% | |
| ✔ | Dividend yield (TTM) | 5.63% | 1.85% | |
| ✘ | Share count, per year | 0.46% | 0.00% | |
| ✘ | Return on capital employed | 5.95% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
58 / 100Priced at or below the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings | 40.15x | 19.60x | |
| ✔ | Free cashflow yield | 6.31% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 2.03x | — | ||
| ✘ | Margin of safety | -50.85% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 15.00 USD is below the current price of 29.39 USD
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 61.9 USD ✔
Current Price: 30.5 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
62 / 100Growing faster than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Revenue growth | 24.66% | 10.97% | |
| ✔ | Earnings growth | 42.60% | 14.48% | |
| ✘ | Cashflow growth | -7.73% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Revenue growth has slowed this year (-0.21% against a five year average of 24.66%)
- ✘Earnings growth has slowed this year (-59.83% against a five year average of 42.60%)
- ✘Free cashflow growth has slowed this year
- ✘Revenue is growing at 24.66% per year while free cashflow is falling at 7.73% per year
Health
43 / 100Balance sheet is stretched on several measures.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 2.13 | 3.00 | |
| ✔ | Piotroski score | 5.00 | 5.00 | |
| ✔ | Debt / equity | 0.75x | 0.80x | |
| ✔ | Current ratio | 1.16x | 1.00x | |
| ✔ | Interest coverage | 3.82x | 2.50x | |
| ✘ | Free cashflow / debt | 0.14x | 0.15x | |
| ✔ | Debt / capital | 0.43x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Dividend
50 / 100Cover is thin on at least one measure.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Dividend yield | 5.63% | 1.85% | |
| ✔ | Dividend growth | 2.72% | 0.00% | |
| ✘ | Payout ratio (earnings) | 225.83% | 40.00% | |
| ✘ | Payout ratio (cashflow) | 89.08% | 65.00% | |
| ✔ | Worst year, last 5 years | 2.30% | -2.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Dividend growth has been slowing recently
Management
54 / 100Returns on capital are at or above the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | 8.99% | 15.00% | |
| ✘ | Return on capital employed | 5.95% | 10.00% | |
| Return on assets | 3.73% | — | ||
| Free cashflow return on capital | 5.30% | — | ||
| ✘ | Return on capital, 5y change | -6.27% | 0.00% | |
| ✘ | Share count, per year | 0.46% | 0.00% | |
| ✘ | Share count, recent | 0.29% | 0.00% | |
| Realized buyback return | N/A | 0.00% | ||
| ✔ | Goodwill erosion / equity | 0.40% | 2.00% | |
| Price volatility, 5 year | 25.48% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘New shares were issued while the value score was 58 out of 100
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
PFE
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Pfizer Inc.
Currency
USD
Beta
0.276
Vol Avg
33754310
Ceo
Dr. Albert Bourla D.V.M., Ph.D.
Cik
0000078003
Cusip
Exchange
NYSE
Full Time Employees
75000
Industry
Drug Manufacturers - General
Sector
Healthcare
Ipo Date
Address
66 Hudson Boulevard East
City
New York
State
NY
Country
United States
Zip
10001-2192
Phone
212 733 2323
Analysis Last Updated
04/11/2026, 12:01:28
Financial data compiled from SEC EDGAR filings and Yahoo Finance.